Good Intentions Are Not a Strategy: The Case for Analytical Philanthropy

In 2007 the Bill & Melinda Gates Foundation made a strategic decision that would reshape global malaria prevention.

Rather than funding a wide range of loosely related health programs, the foundation concentrated resources on a single intervention with unusually strong empirical support: insecticide treated mosquito nets. The reasoning was simple. Randomized field trials had shown that widespread distribution of treated nets could reduce malaria mortality among children by roughly 20 percent in high transmission regions.

The strategy worked. Over the following decade, large scale distribution campaigns supported by governments, international organizations, and philanthropic capital contributed to dramatic declines in malaria deaths across sub-Saharan Africa. According to the World Health Organization, global malaria mortality fell by more than half between 2000 and 2015 (World Health Organization).

The lesson from that effort was not simply that mosquito nets save lives. The deeper lesson was strategic. Philanthropic capital created far greater impact when it was deployed with analytical discipline.

This runs counter to a persistent assumption about philanthropy.

Because the goal is social good rather than financial profit, the work is often framed primarily as a moral activity rather than an analytical one. Strategy is discussed in terms of mission alignment and values rather than measurement and capital allocation.

In reality philanthropy often faces more complex strategic problems than for-profit business.

The Measurement Challenge

Businesses operate within a relatively direct feedback system. When a company launches a product, revenue provides an immediate signal about whether the offering creates value in the market. Leaders can observe results quickly and adjust strategy.

Philanthropy rarely enjoys that clarity.

Most philanthropic organizations aim to influence long horizon social outcomes such as educational attainment, disease burden, housing stability, or economic mobility. These outcomes evolve slowly and are shaped by many actors simultaneously including governments, nonprofits, markets, and community institutions.

As a result, philanthropic leaders rarely receive clear causal signals about which interventions produce the greatest change.

This measurement problem has led many organizations to track outputs rather than outcomes. Foundations often report metrics such as the number of grants issued, the number of program participants served, or the number of organizations funded. These measures describe activity but say little about whether underlying social conditions improved.

Over the past two decades, a growing movement within philanthropy has attempted to address this gap by applying more rigorous analytical methods to the evaluation of social programs.

Evidence Based Philanthropy

One influential example is GiveWell, a nonprofit research organization that evaluates charitable programs using cost effectiveness analysis. Rather than recommending charities based primarily on reputation or mission alignment, GiveWell conducts detailed analysis of the empirical evidence behind interventions.

This analytical approach has reshaped the behavior of many donors. Evidence based philanthropy has gained influence partly because it confronts a difficult truth. Not all charitable programs produce measurable impact, and the difference between effective and ineffective interventions can be enormous.

In other words, philanthropic capital faces the same allocation problem as investment capital: Resources must be directed toward the highest impact opportunities.

Philanthropy as a Portfolio Strategy

Large philanthropic organizations rarely pursue a single intervention. Instead they manage portfolios of initiatives across issue areas, geographies, and time horizons.

A global foundation may simultaneously fund vaccine development, early childhood education programs, climate resilience projects, and nonprofit capacity building. Each initiative carries different probabilities of success and different timelines for impact.

This resembles portfolio management in finance.

Some philanthropic leaders have begun explicitly adopting this perspective. The Mulago Foundation, for example, focuses its funding on what it calls scalable solutions. Rather than dispersing small grants widely, it identifies interventions with the potential to improve millions of lives and concentrates capital on those strategies.

The approach borrows directly from venture capital logic. Early investments support experimentation. Successful interventions receive additional funding to scale.

Learning from Randomized Trials

A major influence on modern philanthropic strategy has been the rise of randomized controlled trials in development economics.

Organizations such as Innovations for Poverty Action and the Abdul Latif Jameel Poverty Action Lab have conducted hundreds of field experiments testing the effectiveness of poverty reduction programs. These studies examine interventions ranging from microfinance to education incentives to health subsidies.

The results have often challenged conventional assumptions. Some programs widely believed to reduce poverty show limited measurable impact. Others that appear modest in scope generate substantial improvements in outcomes.

For philanthropic organizations, these findings have important implications. Evidence can reveal where philanthropic capital creates meaningful change and where it does not.

Philanthropy therefore benefits from the same analytical discipline used in medicine or scientific research.

The Time Horizon of Social Change

Another reason philanthropy requires strategic rigor is the long time horizon of many social outcomes.

Businesses typically evaluate initiatives within three to five year planning cycles. By contrast, many philanthropic goals unfold over decades.

Educational interventions targeting early childhood literacy may not influence workforce outcomes until the children involved reach adulthood. Public health initiatives addressing chronic disease often require sustained investment before measurable population level improvements appear.

Because the causal chain is long, philanthropic organizations benefit from strategies that extend beyond typical corporate planning cycles. Ten year frameworks allow leaders to invest patiently, test multiple approaches, and adapt as evidence emerges.

Why Rigor Matters

The consequences of poor strategy differ between business and philanthropy.

When a company misallocates capital, investors experience financial loss. When philanthropic capital is misallocated, the cost appears as lost opportunity to improve human lives.

That difference raises the stakes of strategic decision making.

Generosity determines the size of philanthropic capital. Strategy determines how effectively that capital produces change.

Key Takeaways

• Philanthropic organizations face measurement challenges that are often more complex than those encountered by businesses.

• Evidence based philanthropy applies analytical tools such as cost effectiveness analysis and randomized trials to identify interventions that produce measurable impact.

• Large foundations implicitly manage portfolios of social investments and benefit from strategies similar to those used in investment management.

• Long horizon strategies allow philanthropic organizations to address social challenges whose outcomes unfold over decades.

• Analytical rigor does not conflict with compassion. It increases the probability that philanthropic capital produces meaningful and lasting change.

How RLK Helps

RLK Consulting works with leadership teams to translate ambitious goals into structured strategies that can be executed and evaluated over time.

For philanthropic organizations, this includes clarifying theories of change, structuring portfolios of initiatives, defining measurable outcomes, and building governance processes that allow leaders to learn and adapt over long horizons.

The objective is simple: Increase the probability that philanthropic capital produces durable social impact.

Sources

Banerjee, Abhijit V., and Esther Duflo. Poor Economics: A Radical Rethinking of the Way to Fight Global Poverty. PublicAffairs, 2011.

GiveWell. “Insecticide-Treated Nets.” GiveWell Research.

Innovations for Poverty Action. “About IPA.” Innovations for Poverty Action.

Mulago Foundation. “Our Approach.” Mulago Foundation.

World Health Organization. World Malaria Report 2023. World Health Organization, 2023.